Several groundbreaking medications are transforming blood sugar treatment, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide emerging as promising choices. Retatrutide, a twin GIP and GLP-1 receptor stimulant, demonstrates remarkable fat reduction along with better blood sugar control. Cagrillintide, a GLP-1 activator, is now in medical